VR headsets tested as a possible treatment for blindness

NCT ID NCT07071129

Terminated Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated early and only enrolled 22 participants, so we don't yet know if this approach works in humans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual reality visual stimulation (device)
What this could lead to: If it works, this could point toward a non-invasive way to partially restore vision in people with glaucoma or retinal damage.
What could go wrong: This was a very small, early study that was terminated, so results are limited. The approach is still experimental and may not work in humans as it did in rodents.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISORDER OF THE VISUAL SYSTEM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disorder of visual system glaucoma retinal disorder vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA VISION DISORDER

Contacts and locations

Show contact details

Locations

Byers Eye Institute at Stanford University

Palo Alto, California, 94303, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.